Serum potassium changes due to concomitant ACEI/ARB and spironolactone therapy: A systematic review and meta-analysis | Zendy

Lorenzo Villa Zapata | Zendy; Briggs Carhart | Zendy; John R. Horn | Zendy; Philip D. Hansten | Zendy; Vignesh Subbian | Zendy; Sheila M. Gephart | Zendy; Malinda Tan | Zendy; Andrew Romero | Zendy; Daniel C. Malone | Zendy

AI Assistant Blog Pricing

Open Access

Serum potassium changes due to concomitant ACEI/ARB and spironolactone therapy: A systematic review and meta-analysis

Author(s) -

Lorenzo Villa Zapata,

Briggs Carhart,

John R. Horn,

Philip D. Hansten,

Vignesh Subbian,

Sheila M. Gephart,

Malinda Tan,

Andrew Romero,

Daniel C. Malone

Publication year - 2021

Publication title -

american journal of health-system pharmacy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.487

H-Index - 96

eISSN - 1535-2900

pISSN - 1079-2082

DOI - 10.1093/ajhp/zxab215

Subject(s) - spironolactone , medicine , meta analysis , publication bias , combination therapy , pharmacology , endocrinology , aldosterone

To provide evidence of serum potassium changes in individuals taking angiotensin-converting enzyme inhibitors (ACEIs) and/or angiotensin receptor blockers (ARBs) concomitantly with spironolactone compared to ACEI/ARB therapy alone.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog